Intimation pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding Press release - Aptus Pharma expands OTC presence in Gujarat, Strengthens Cosmeceutical Portfolio
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Limited has announced the expansion of its over-the-counter (OTC) business in Gujarat through its dedicated Aptus Well Care Division. The expansion targets high-demand consumer categories including face care, body and skin care, and hair care, driven by flagship brands such as Timglo, Kerava, and Shirovita. The company plans to broaden its portfolio with future launches in hygiene care, pain relief, and oral care, along with new SKUs like Timglo Detox and Kerava Shea Moisturizer. To support this move, Aptus Pharma is increasing its field force and distributor network to place OTC products in a larger number of medical stores across Gujarat.
This is a strategic growth announcement focusing on market share expansion in Gujarat's OTC segment rather than a specific order or financial result. Shareholders should view this as a positive but largely forward-looking signal of growth intent, with no immediate revenue or earnings impact quantifiable from the filing.